Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118542) titled 'A single-arm, single-center, exploratory study of cetuximab beta combined with definitive chemoradiotherapy for elderly patients with locally advanced unresectable esophageal squamous cell carcinoma' on Feb. 6.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Anhui Provincial Cancer Hospital

Condition: esophageal squamous cell carcinoma

Recruitment Status: Not Recruiting

Phase: 0

Date of First Enrollment: 2026-03-01

Target Sample Size: experimental group:47;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=306719

Disclaimer:...